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Background: Few studies have examined young adults with type 1 diabetes use of health services and the
development of vascular complications. As part of the Youth Outreach for Diabetes (YOuR-Diabetes) project,
this study identified health service usage, the prevalence and factors predictive of development of vascular
complications (hypertension, retinopathy and nephropathy) in a cohort of young adults (aged 16–30 years) with
type 1 diabetes in Hunter New England and the Lower Mid-North Coast area of New South Wales, Australia.
Methods: A cross-sectional retrospective documentation survey was undertaken of case notes of young adults with
type 1 diabetes accessing Hunter New England Local Health District public health services in 2010 and 2011,
identified through ambulatory care clinic records, hospital attendances and other clinical records. Details of service
usage, complications screening and evidence of vascular complications were extracted. Independent predictors
were modelled using linear and logistic regression analyses.
Results: A cohort of 707 patients were reviewed; mean (SD) age was 23.0 (3.7) years, with mean diabetes duration
of 10.2 (5.8, range 0.2 - 28.3) years; 42.4% lived/ 23.1% accessed services in non-metropolitan areas.
Routine preventative service usage was low and unplanned contacts high; both deteriorated with increasing age.
Low levels of complications screening were found. Where documented, hypertension, particularly, was common,
affecting 48.4% across the study period. Diabetes duration was a strong predictor of vascular complications along
with glycaemic control; hypertension was linked with renal dysfunction.
Conclusion: Findings indicate a need to better understand young people’s drivers and achievements when
accessing services, and how services can be reconfigured or delivered differently to better meet their needs and
achieve better outcomes. Regular screening is required using current best practice guidelines as this affords the
greatest chance for early complication detection, treatment initiation and secondary prevention.
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Life expectancy and quality of life for people with type 1
diabetes are limited by the development of vascular com-
plications such as nephropathy, retinopathy and hyper-
tension, not least because such vascular changes lead to
kidney failure and blindness, cardiac disease, stroke and
limb amputations [1]. A systematic literature review of
the prevalence and factors predictive of development of* Correspondence: Lin.Perry@uts.edu.au
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betes found few studies specifically recruited or even in-
cluded representative samples, but that such complications
were common even in youthful populations [2]. Few stud-
ies sought to determine factors predictive of development
of these complications, but those most consistently re-
ported, particularly amongst older groups, were diabetes
duration, glycaemia and blood pressure (BP) control.
The onset of complications in early adulthood is par-
ticularly detrimental because of the loss of life years and
restricted social participation at an age when it is more
usually maximal. Early adulthood years are particularlytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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management are established. Young adults with type 1
diabetes may be particularly vulnerable to the develop-
ment of complications as they may not receive disease-
specific or age-appropriate care, and may disengage from
the support of diabetes services when they leave the
paediatric services they grew up with, at an age when ad-
herence to diabetes self-management regimens is often
reported as suboptimal [1,3-5]. Case note audit of young
adults with type 1 diabetes accessing diabetes services
in the state capital, a city and regional areas of New
South Wales (NSW) in Australia demonstrated inadequate
routine specialist care, poor self-management and frequent
use of acute services for crisis management, particularly
in regional areas [4]; however, sample sizes were small.
Paucity of data on health service usage by young adults
with type 1 diabetes for diabetes-related care, prevalence
and predictors of vascular complications limits determin-
ation of the extent of the problem and hence appropriate
service prioritisation.
This study aimed to identify the health service usage,
prevalence and factors predictive of development of vascu-
lar complications (hypertension, retinopathy and nephrop-
athy) in a cohort of young adults with type 1 diabetes in
NSW.
Methods
This cross-sectional retrospective documentation survey
was part of the Youth Outreach for Diabetes (YOuR-
Diabetes) project, an Australian National Health and
Medical Research Council funded service development
and evaluation initiative for young adults with type 1
diabetes in the Hunter New England (HNE) and Lower
Mid-North Coast region of NSW. Research partners
were the Australian Diabetes Council and Hunter New
England Health (HNEH), the public health service pro-
vider for approximately 850,000 residents across 130,000
square kilometres of NSW, including metropolitan New-
castle and regional/rural areas [6]. Specialist services for
type 1 diabetes in the region and more widely have been
described elsewhere [4,7,8].
Participants
Participants were young adults (aged 16–30 years) with
type 1 diabetes as a primary condition. We collated our
database from patient occasions of service with HNEH
services from 2008 onwards, and audited contacts during
2010 and 2011. In Newcastle participants were identified
through ambulatory care clinic records and Emergency
Department (ED) and hospital attendances. In regional
areas, records of Community Health, local diabetes educa-
tors and pathology services were also searched. We endea-
voured to identify all young people with type 1 diabetes in
the Local Health District, but recognised that our databasemay miss any who did not use state public health services,
whose management and outcomes may be dissimilar to
those reported.
Data collection
Paper and electronic health records - individual case notes
and multi-disciplinary documentation - were reviewed
and data extracted using methods developed previously
[4], and the criteria listed in Table 1; 95% agreement was
demonstrated between two experienced data extractors.
Planned and unplanned diabetes-related service contacts
were the primary study outcomes: routine diabetes pre-
ventive care consultations with a doctor, diabetes nurse
educator and/or dietitian; and unplanned presentations at
any HNEH ED and/or acute hospitalisation for diabetes-
related complaints. ED presentations resulting in hospital
admission were solely recorded as hospitalisation.
Vascular complications were the secondary study
outcomes. Data extracted included: BP measurements
(number; values), ophthalmic examinations (number;
documented absence/presence of retinopathy) and urinary
albumin to creatinine ratio (ACR) measurements indicative
of nephropathy (number; values): see Table 1 for definitions
[9-11]. Data related to factors potentially predictive of de-
velopment of vascular complications were also extracted.
Socio-demographic data included age at diagnosis and area
of residence [12] as these factors are recognized as impact-
ing access and attendance at diabetes services [13,14].
Glycaemic control was determined by HbA1c assess-
ments (number; values) classified in relation to an optimal
target of less than or equal to 7.0% (53 mmol/mol) [9-11].
As the Australian Diabetes Society [15] advocates HbA1c
be maintained at up to 8.0% (64 mmol/mol) for those
with severe hypoglycaemic episodes or hypoglycaemia un-
awareness, mean HbA1c was further classified as equal to
or above 8.0% (64 mmol/mol). Continuous Subcutaneous
Insulin Infusion (CSII) use was noted as these devices have
potential to improve diabetes management [16].
Data extracted for other factors shown to influence
vascular disease risk were: smoking status, weight and
height assessments, and Body Mass Index (BMI) calcu-
lations (number; values). BMI was firstly categorised as
below 18.5 kg/m2 (underweight), 18.5 - 24.9 kg/m2 (on
target), 25–29.9 kg/m2 (overweight) and equal to or above
30 kg/m2 (obese) [17].
Ethical approvals were obtained from Hunter New
England, University of Newcastle and University of Tech-
nology, Sydney Human Research Ethics Committees.
Analyses
Data were entered into SPSS version 21 for analyses. Fre-
quencies, means and standard deviations were used de-
scriptively according to the level of the variable for service
usage, vascular complications and potential predictive
Table 1 Study definitions of vascular complications
Complication Complication present when:
Hypertension Mean systolic or diastolic BP values≥ 130/80 mmHg, respectively per annum, and/or prescription of anti-hypertensive medication
Retinopathy Retinopathy documented
Nephropathy At least one reported ACR measurement above laboratory threshold normal value
ACR: Albumin to creatinine ratio. BP: Blood pressure.
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and without vascular complications using Chi-square and
t-tests; Pearson’s correlation coefficients were used be-
tween mean systolic and diastolic BP values and potentially
linked characteristics such as planned, unplanned and total
service contacts, mean HbA1c and BMI values, and dia-
betes duration. Associations between service usage, age
and duration with diabetes were sought using multiple re-
gression. Independent predictors of vascular complications
were determined by logistic regression analysis, with separ-
ate models developed for hypertension, nephropathy and
presence of any of the three vascular complications. For
the analysis of these three models only, absence of evi-
dence of documented vascular complications, laboratory
values and smoking were treated as absence of that com-
plication or potential predictive factor. No modelling was
undertaken for retinopathy alone as reported cases were
too few in number. Predictor variables were determined
from the literature review and preliminary analyses of
association. All three models included forced entry of the
variables: any planned or unplanned health service contact,
sex, metropolitan versus regional/rural residence, CSII
use, smoking, mean HbA1c (used as a continuous variable
and categorised as below, or equal to or above 8.0%
(64 mmol/mol over the two years)), and diabetes duration
[4,13,18-24]; hypertension was included as a variable in the
analyses for nephropathy. BMI values were not included in
regression analyses as assumptions of the analyses for a lin-
ear relationship were violated when used either as continu-
ous or categorical variables. The critical level for retention
in the model was set at 0.05. All assumptions of regression
analysis were tested and met, including multi-collinearity.
Results
A total of 707 individual case records were identified,
with data available for 682 and 707 cohort members in
2010 and 2011, respectively. At the end of the two-year
study period the mean (SD) age of the cohort was 23.0
(3.7) years. The sexes were approximately equally repre-
sented with 384 (54.3%) male; 39 (5.6%) were docu-
mented as Aboriginal and/or Torres Strait Islander.
Mean (SD, range) diabetes duration was 10.2 (5.8, 0.2 -
28.3) years, with median 3.0 years of adult service usage.
A minority of 299 (42.4%) cohort members lived and
112 (23.1%) accessed services outside of a major city.
With no clear record of insulin delivery method for 103(14.6%) cohort members, 154 (21.8%) were current and
36 (5.1%) intermittent CSII users. The profiles of CSII
and non-CSII users differed: CSII users were signifi-
cantly older (mean age 22.9 versus 21.5 years; t = 5.011,
p < 0.001); had diabetes longer (mean 11.2 versus
9.8 years; t = 2.886, p < 0.004); received more planned
service contacts/two years (mean 11.5 versus 6.25 con-
tacts; t = 6.535, p < 0.001); more HbA1c measurements/
two years (mean 4.2 versus 2.6 measurements; t = 6.353,
p < 0.001); more BP measurements/two years (mean 2.6
versus 1.5 measurements; t = 5.523, p < 0.001); and more
ACR measurements/two years (mean 1.0 versus 0.7
measurements; t = 3.291, p < 0.002).
Service usage
Routine health service usage was low; 280 (41.1%) and
306 (43.5%) cohort members had no planned service
contact recorded during 2010 or 2011. Where a planned
service did occur, a median of six individual planned
contacts (range 1–52) with healthcare providers (i.e.
consultations with doctors, nurses and dieticians) were
undertaken across the two-year study period.
Unplanned service contacts were common; 308
(45.2%) and 326 (46.1%) members had at least one
diabetes-related ED presentation and/or hospitalisation
during 2010 or 2011; of those who had any unplanned
contact an overall median of two contacts (range 1–22)
occurred. Unplanned contacts occurred more frequently
amongst those who had evidence of retinopathy or ne-
phropathy: for example, 90% of those who had retinop-
athy versus only 61.4% of those without documented
retinopathy had at least one unplanned service contact.
A median of eight (range 1–62) planned/unplanned
contacts were reported, with 178 and 184 (26.1% in each
year) cohort members having no reported service con-
tact, planned or unplanned, and 87 (12.8%) having no
service contact over the two years.
There was a significant negative correlation between age
and total number of planned contacts/two years (Pearson
R = −0.339, p < 0.001) and significant but weaker association
with duration since diagnosis (R = −0.168, p < 0.001; overall
model fit R2 = 0.120). Multiple regression analysis demon-
strated significant relationships between increasing age and
fewer planned contacts (Beta = −0.321, p < 0.001), whilst the
relationship with diabetes duration was not significant
(overall model fit R2 = 0.118). A similar pattern was seen
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whilst still significant, this was much weaker, i.e. increas-
ing age was more strongly linked with reducing use of
preventive care than acute service usage.
Vascular complications
Low levels of screening and/or documentation were re-
corded but evidence indicated presence of co-morbid
disease (Table 2). The majority had no documented BP
measurement, ophthalmic examination or ACR meas-
urement during either 2010 or 2011, respectively. Pre-
scription records were unavailable for 269 (38%) and a
prescription for anti-hypertensive medication was docu-
mented for 72 (10.2%). A total of 201 (48.4%) partici-
pants were classified as hypertensive on the basis of
at least one documented elevated BP measurement or
anti-hypertensive medication prescription. At least one
documented BP measurement equal to or above 130/
80 mmHg was reported in 35 (48.6%) cohort members
prescribed anti-hypertensive medication, across the
study period.
Of those who had a documented ACR measurement,
137 (40.1%) had two or more and 17 (12.4%) of these
had two or more above the threshold value. Those who
used CSII were reported to have some form of vascular
complication (hypertension, retinopathy and/or ne-
phropathy) at a similarly high frequency to non-CSII
users (55.6% affected versus 53.8%), but overall nearly
40% of the sample were eliminated from these analyses
due to incomplete data (n = 428 included).
Vascular risk factors
Low levels of documented risk factors were also evident












ACR measurements above threshold value^
At least one
ACR: Albumin to creatinine ratio. BP: Blood pressure.
^ Three cohort members excluded from analysis for 2010 as measurement undertamedian of three measurements were documented (range
1–12) across the two year study period. In cohort mem-
bers identified as having hypertension, retinopathy and/
or nephropathy, a minority of 67 (36.6%), 6 (30.0%) and
15 (26.8%) had mean recorded HbA1c below 8.0%
(64 mmol/mol), respectively.
Although records of smoking were incomplete for 387
(54.7%), 94 (13.3%) were reported as current smokers.
No weight was recorded for 38.8%, and a median one
weight assessment per person (range 1–11) was docu-
mented. Height measurement was not documented for
259 (36.6%).
Associations between risk factors and vascular
complications
Cohort members were more likely to have documented
hypertension if they were male (55.7% versus 41.0%,
Chi2 = 9.02, p = 0.003) or had none rather than any un-
planned service contact (55.4% versus 44.3%, Chi2 = 9.36,
p < 0.003). Higher mean systolic BP values were linked
to older age (r = 0.339, p < 0.001), longer diabetes duration
(r = 0.168, p < 0.002), (unsurprisingly) higher mean diastolic
values (r = 0.639, p < 0.001), greater BMI values (r = 0.210,
p < 0.004), fewer planned (r = −0.167, p < 0.002), un-
planned (r = −0.169, p < 0.001) and total service contacts
(r = −0.201, p < 0.001).
Similar associations were seen with mean diastolic BP
values, with higher recordings linked to older age (r = 0.302,
p < 0.001), longer diabetes duration (r = 0.214, p < 0.001),
greater mean HbA1c (r = 0.178, p < 0.001) and fewer
planned (r = 0.109, p < 0.033) and total service contacts
(r = −0.106, p < 0.038).
Cohort members who had retinopathy in comparison
to those who did not were significantly older (mean ageoutcomes
2010 2011
Number (%) Number (%)
(n = 682) (n = 707)
313 (45.9) 306 (43.3)
(n = 313) (n = 306)
106 (33.9) 94 (30.7)
(n = 682) (n = 707)
95 (14) 85 (12)
(n = 95) (n = 85)
13 (13.7) 8 (9.4)
(n = 682) (n = 707)
222 (32.6) 218 (30.8)
(n = 219) (n = 218)
33 (15.1) 35 (16.1)
ken but result unknown.
Table 3 Vascular disease risk factors
Variable 2010 2011
Number (%) Number (%)
HbA1c documented (n = 682) (n = 706)
At least one 422 (61.9) 425 (60.2)
HbA1c value (s) ≤ 7.0% (53 mmol/mol) documented in those with ≥ 1 recorded (n = 422) (n = 425)
At least one 104 (24.6) 95 (22.4)
HbA1c value (s) ≥ 8.0% (64 mmol/mol) documented in those with ≥ 1 recorded (n = 422) (n = 425)
At least one 295 (69.9) 293 (68.9)
Mean HbA1c (n = 422) (n = 425)
≥ 8.0% (64 mmol/mol) 260 (61.6) 269 (63.3)
Weight documented (n = 683) (n = 707)
At least one 340 (49.8) 345 (48.8)
Mean BMI (n = 272) (n = 255)
< 18.50 kg/m2 5 (1.8) 4 (1.6)
18.50 - 24.99 kg/m2 160 (58.8) 137 (53.7)
≥ 25–29.99 kg/m2 69 (25.4) 74 (29)
≥ 30 kg/m2 38 (14) 40 (15.7)
BMI: Body Mass Index
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longer diabetes duration (mean 14.1 versus 11.0 years;
t = −2.531, df 143, p < 0.021) and more unplanned ser-
vice contacts over the two-year period (mean 4.4 versus
1.8 contacts; t = 2.885, df 22, p < 0.009).
Cohort members who had any recorded ACR meas-
urement above threshold values in comparison to those
who did not were significantly older (mean 23.2 versus
22.0 years; t = −2.381, df 332, p < 0.018) and had signifi-
cantly higher mean HbA1c values across the two-year
period (9.4% versus 8.6%; t = −3.174, df 327, p < 0.002).
They were more frequently documented with hyperten-
sion (68.2% versus 42.0%, Chi2 = 10.2, p < 0.001).
Independent predictors of vascular complications
Logistic regression analysis revealed that cohort members
were more likely to have hypertension (model Chi2 = 45.34,
df 7, p < 0.001) if they had no (rather than any) health ser-
vice contact (OR 0.21, 95% CI 0.1 - 0.51, p = 0.001), any
use of CSII (OR 1.8, 95% CI 1.2 - 2.7, p = 0.004) or a
longer diabetes duration (each year, OR 1.05, 95% CI
1.01 - 1.09, p = 0.006). The odds of having nephropathy
(model Chi2 = 42.95, df 8, p < 0.001) were increased
more than three times by having hypertension (OR 3.19,
95% CI 1.66 - 6.15, p < 0.001) and having a mean HbA1c
at or greater than 8.0% (64 mmol/mol) (OR 3.59, 95%
CI 1.67 - 7.74, p = 0.001) (Table 4).
The likelihood of documented hypertension, retinopathy
and/or nephropathy (model Chi2 = 58.02, df 7, p < 0.001)
increased with absence of health service contact (OR 0.17,
95% CI 0.07 - 0.41, p < 0.001), with any CSII use (OR 1.78,95% CI 1.19 - 2.64, p = 0.005), a mean HbA1c equal to or
above 8.0% (64 mmol/mol) (OR 1.64, 95% CI 1.13 - 2.38,
p = 0.01) and longer diabetes duration (each year, OR
1.05, 95% CI 1.02 - 1.09, p = 0.003) (Table 4). Statistical
significance was attenuated or lost for these variables
when mean recorded values for HbA1c and BP were
employed.
Discussion
The study findings are broadly representative across
metropolitan, regional and rural Australia as they present
data from 707 young adults of a potential 830 people with
type 1 diabetes within this age band registered on the
National Diabetes Services Scheme (personal communica-
tion), a ‘best option’ source for population figures for this
mobile group. Findings demonstrated young adults with
type 1 diabetes in this region of NSW at risk of poor
health outcomes. Low attendance for preventive care, and
shortcomings according to international standards [9-11]
in the screening they received when they attended, re-
duced sample size for many analyses; consequently some
associations, whilst statistically significant, showed low ex-
planatory power. Nonetheless, data indicated inadequate
access/uptake of routine preventive care and increasing
age of patients accompanied by a more significant pattern
of reducing use of routine preventive care than use of
acute services for diabetes crisis management.
Data were indicative or suggestive of co-morbid dis-
ease, consistent with systematic review findings [2].
Where assessed, one in six cohort members had at least
one recorded episode of microalbuminuria and as many
Table 4 Predictors of hypertension, nephropathy and any vascular complication (hypertension, retinopathy and/or
nephropathy)
Predictor Hypertension Nephropathy Hypertension, retinopathy and/or
nephropathy
B 95% CI p value B 95% CI p value B 95% CI p value
Any CSII use 1.8 1.2 - 2.7 0.004 1.06 0.54 - 2.08 0.877 1.78 1.19 - 2.64 0.005
Male 1.42 0.97 - 2.08 0.069 0.58 0.28 - 1.03 0.062 1.16 0.8 - 1.68 0.424
Mean HbA1c ≥ 8% 1.42 0.96 - 2.09 0.077 3.59 1.67 - 7.74 0.001 1.64 1.13 - 2.38 0.01
Smoking 1.34 0.91 - 1.96 0.135 1.2 0.63 - 2.29 0.572 1.3 0.9 - 1.88 0.17
Diabetes duration 1.05 1.01 - 1.09 0.006 0.99 0.93 - 1.06 0.831 1.05 1.02 - 1.09 0.003
Metropolitan residence 0.92 0.63 - 1.37 0.69 1.184 0.6 - 2.32 0.623 0.97 0.66 - 1.42 0.868
No reported service contact 0.21 0.1 - 0.51 0.001 0.17 0.07 - 0.41 < 0.001
Hypertension N/A 3.19 1.66 - 6.15 0.001 N/A
Constant 0.16 < 0.001 0.3 < 0.001 0.21 < 0.001
Model Statistics Chi2 = 45.34, df 7, n550, p < 0.001 Chi2 = 42.95, df 8, n550, p < 0.001 Chi2 = 58.02, df 7, n550, p < 0.001
CSII: Continuous Subcutaneous Insulin Infusion. N/A: Not applicable.
No modelling undertaken for retinopathy independently or analyses of no health service contact as a predictor of nephropathy as too few cases.
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BP equal to or above 130 mmHg and/or 80 mmHg, re-
spectively; almost one in two were affected when medica-
tion for hypertension was included. One in nine had
documented retinopathy; less than demonstrated for
young adults in NSW between 1990–2000 [25], but con-
sistent with more recent NSW adolescents’ data from
2005–2009 [26]. Whilst a reduction in retinopathy pre-
valence over time may have been related to changes in
diabetes management following the definitive Diabetes
Control and Complications Trial [22] which made gly-
caemic control central, low levels of screening potentially
under-estimates the true level of retinopathy in this co-
hort; also hypertension and nephropathy. Collectively,
these data are cause for concern, indicating low use of pre-
ventive services reducing with increasing age accompanied
by early onset of co-morbid disease, increased risk of im-
paired quality of life and premature mortality.
Despite guidelines recommending use of angiotensin
converting enzyme or angiotensin 2 receptor blockers
even in children, few of this cohort were in receipt of
treatment or treated to target. Only one in ten were doc-
umented as prescribed anti-hypertensive medication and
of those that were, two in three had mean BP equal to
or above 130/80 mmHg across the study period; poten-
tially indicating missed opportunities for disease modifi-
cation. This is particularly regrettable since elsewhere
rates of anti-hypertensive prescription have been re-
ported as increasing significantly, to 34.2% in 2007 [27].
Internationally accepted standards for glycaemia man-
agement were largely not met [9-11], with inadequate
HbA1c monitoring and two-thirds of cohort members with
at least one measurement within the two-year period hav-
ing mean HbA1c at or greater than 8.0% (64 mmol/mol).However, the Epidemiology of Diabetes Interventions and
Complications (EDIC) Study [28] found similar HbA1c
values, increasing in adolescents in the intensive treatment
group (from 8.1% to 8.4%) and decreasing (but still ele-
vated) in the conventional treatment group (from 9.8% to
8.5%) after study end. These data suggested it may be diffi-
cult to maintain HbA1c values under 8.0% in young people
outside a clinical trial. Data from this location in NSW ap-
pear consistent with this conclusion.
Findings regarding the use of CSII were noteworthy.
Whilst CSII users received overall significantly greater
planned service use and assessments, hypertension and
any vascular complication occurred more frequently in
association with any usage of CSII. Results should be
viewed with caution due to missing data but whilst find-
ings were not in line with some studies [16] they were
consistent with a previous NSW study which showed
that while CSII use doubled during the study period,
HbA1c in users deteriorated, rising from 8.4% to 8.6%
[3]. It is tempting to speculate that perhaps people with
poor control of blood glucose, and associated hyper-
tension, may have been started on CSII in an attempt to
improve control, but most of these young people were
likely to have commenced use of CSII as children. Edu-
cation at initiation of CSII for children is primarily to
parents/responsible adults. If the child/teen was not
targeted for education pre-transition from paediatric
care, deficiencies in CSII knowledge were not likely to
have been picked up or rectified if the young adult did
not have a good relationship with a pump-specialist.
Subsidised access to CSII combined with greater access
to specialist support for children has resulted in expan-
sion of CSII use particularly amongst children [29], with
trends to start CSII use at diagnosis gaining favour. This
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management such CSII users are, as they move into
adulthood and lose access to paediatric specialist ser-
vices. Further research is needed to examine whether
and how insulin pumps may deliver on their promise of
improved diabetes control for people with type 1 dia-
betes [29]. Given the cost in provision of CSII and the
human resources required to support pump users, the
possibility that they may not improve outcomes is too
important to ignore. Whilst there may be many reasons
for a decline in management of diabetes and its compli-
cations in young adults using insulin pumps, one might
be that stretched diabetes teams lack adequate specialist
resources to provide the more complex and time con-
suming support needed to optimise results.
Over half of this cohort resided in a major city, and
half of those who did not travelled there to access spe-
cialist diabetes services. Inadequate access to routine
specialist care in regional areas may have contributed to
low uptake and increasing attrition with age from rou-
tine preventive care services, infrequent screening and
suboptimal outcomes. Geographical and socioeconomic
factors have been cited as major issues in access to dia-
betes services, and strong predictors of attendance [14].
Improved diabetes management has been shown by
those who maintain contact and relationships with their
diabetes healthcare teams [13]. However, this may be a
simplistic interpretation. Patterns of use of planned and
unplanned service contacts suggest these young people
were not routinely or systematically using preventive ser-
vices to support their self-care; instead, emergency and
acute services appeared to be being used with almost
half of cohort members having at least one diabetes-
related ED presentation and/or hospitalisation in 2010
and similarly in 2011. Emergency hospital admission can
be seen as an indicator of poor quality of diabetes care
[30], with concerns raised at the education provided by
healthcare staff in this situation [31].
A chief limitation of this study was use of data origin-
ally collected as patient clinical healthcare records; all
such studies are forced to rely on professional and legal
accountability for clinical record-keeping, and the value
attached to record quality in such situations of life-long
care. Nonetheless study data will have been affected by
factors affecting the quality of clinical record keeping.
Whilst there was potential for Berkson’s bias on results,
lack of access to General Practice (GP) or private prac-
tice data mean their service episodes were not reflected
in these findings except as secondary report within case
notes. However, few local GPs offered specialist support
for type 1 diabetes; our previous qualitative study with this
population reported their experience of GP diabetes
care as predominantly age-inappropriate and non-
specialist, and private endocrinologists as unaffordable[32]. Thus this may not have materially affected findings.
The two-year time period of the study did not allow for
trends across time, and the representative nature of these
data can only be estimated by comparison to the earlier
study, which revealed that little had changed over time [4].
Study co-morbidity definitions (specifically hypertension
and nephropathy) were somewhat simplistic and data were
not collected about acute illness and other co-morbidities
that may affect screening and disease management. Fur-
thermore, considering the high prevalence of type 2 diabetes
in Aboriginal and/or Torres Strait Islander populations
[33,34] a few may have been documented incorrectly with
type 1 diabetes based on insulin administration. None-
theless, the strengths of this study lie with the size of the
cohort, the geographical size and range from which the
cohort derives, and its near-complete population sam-
pling within this under-researched age group.Conclusion
Findings flag a need to better understand young people’s
drivers and achievements when accessing services, and
how services can be reconfigured or delivered differently
to engage young people with age-appropriate care that bet-
ter meets their needs to achieve improved outcomes and
defer development of complications. In line with national
guidelines [10], most type 1 diabetes should be managed
by a multidisciplinary specialist health-care professional
team, including in the rural and regional setting, where
diabetes care may be provided by a locally based paediatri-
cian, physician and/or GP on a shared care basis with a
multidisciplinary diabetes care team. In many locations
this will require reconfiguration and appropriate appor-
tionment of resourcing of multidisciplinary teams in both
urban and rural areas, particularly in view of the highly
specialist needs of the increasing number of people with
diabetes using CSII. Health professionals need to work out
ways to enable regular screening to be performed using
current best practice guidelines as this affords the greatest
chance for early complication detection and hence for ini-
tiation of treatment and secondary prevention.
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